Clinical trials
Phase 1/2 Pulmonary Fibrosis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2011 | 1 |
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1 |
| Recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| Paul Szabolcs | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 3 |
| Albinism | 1 |
| Albinism, Oculocutaneous | 1 |
| Anemia, Aplastic | 1 |
| Emphysema | 1 |
| Hermanski-Pudlak Syndrome | 1 |
| Idiopathic Pulmonary Fibrosis | 1 |
| Liver Cirrhosis | 1 |
| Lung Diseases | 1 |
| Metabolic Diseases | 1 |
Trials
Showing 1 to 3 of 3. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.